pharmaphorum June 14, 2023
Phil Taylor

A new US start-up, STAT Health, has emerged from the shadows with $5.1 million in funding to develop an in-ear wearable device that can measure blood flow in the brain, which it says is the “missing vital sign”.

According to the company, the earbud-like device could help researchers get to the bottom of complex and poorly understood health conditions like long COVID, postural orthostatic tachycardia syndrome (POTS), and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

What these disorders have in common are symptoms such as dizziness, brain fog, headaches, fainting, and fatigue, that can get worse when the patient stands up and are all thought to be associated with reduced cerebral blood flow (CBF).

That can be measured using ultrasound technology, but...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Technology, Wearables
Oura Ring Is ‘Like An Apple Product’ And Could Take Key Health Metric Mainstream
Wearable ultrasound sensor revolutionizes continuous blood pressure monitoring
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Driving Urgent Change To Optimize The Patient Experience
Sibionics Blood Glucose Sensor: Review

Share This Article